ES2192183T3 - Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii. - Google Patents
Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii.Info
- Publication number
- ES2192183T3 ES2192183T3 ES00975916T ES00975916T ES2192183T3 ES 2192183 T3 ES2192183 T3 ES 2192183T3 ES 00975916 T ES00975916 T ES 00975916T ES 00975916 T ES00975916 T ES 00975916T ES 2192183 T3 ES2192183 T3 ES 2192183T3
- Authority
- ES
- Spain
- Prior art keywords
- imidazopiridine
- phosphodesterase
- vii
- inhibitors
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
Abstract
Compuestos de la fórmula I **fórmula** en la que R1 significa CONR4R5, R2 significa H o A,R4,R5 significan, respectivamente, de manera independiente entre sí H o A1,R3 significa Hal, Hal significa F, Cl, Br o I, A significa alquilo con 1 a 4 átomos de carbono, A1 significa alquilo con 1 a 10 átomos de carbono, X significa alquileno con 1 a 4 átomos de carbono, pudiendo estar reemplazado un grupo etileno también por un enlace doble o triple, así como a sus sales y/o solvatos fisiológicamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19953414A DE19953414A1 (de) | 1999-11-06 | 1999-11-06 | Imidazopyridinderivate als Phospodiesterase VII-Hemmer |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192183T3 true ES2192183T3 (es) | 2003-10-01 |
Family
ID=7928107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00975916T Expired - Lifetime ES2192183T3 (es) | 1999-11-06 | 2000-10-25 | Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6613778B1 (es) |
EP (1) | EP1226143B1 (es) |
JP (1) | JP2003513973A (es) |
KR (1) | KR20020044591A (es) |
CN (1) | CN1387530A (es) |
AR (1) | AR026352A1 (es) |
AT (1) | ATE236157T1 (es) |
AU (1) | AU775993B2 (es) |
BR (1) | BR0015324A (es) |
CA (1) | CA2388729A1 (es) |
CZ (1) | CZ20021416A3 (es) |
DE (2) | DE19953414A1 (es) |
DK (1) | DK1226143T3 (es) |
ES (1) | ES2192183T3 (es) |
HU (1) | HUP0203245A3 (es) |
MX (1) | MXPA02004448A (es) |
NO (1) | NO20022124D0 (es) |
PL (1) | PL355022A1 (es) |
PT (1) | PT1226143E (es) |
SK (1) | SK5732002A3 (es) |
WO (1) | WO2001034601A2 (es) |
ZA (1) | ZA200204510B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264843C (zh) * | 2001-12-13 | 2006-07-19 | 第一阿斯比奥制药株式会社 | 具有pde7抑制作用的吡唑并嘧啶酮衍生物 |
DE10163991A1 (de) * | 2001-12-24 | 2003-07-03 | Merck Patent Gmbh | Pyrrolo-pyrimidine |
JP2006219374A (ja) | 2003-06-13 | 2006-08-24 | Daiichi Asubio Pharma Co Ltd | Pde7阻害作用を有するイミダゾトリアジノン誘導体 |
JP2006219373A (ja) * | 2003-06-13 | 2006-08-24 | Daiichi Asubio Pharma Co Ltd | Pde7阻害作用を有するピリジニルピラゾロピリミジノン誘導体 |
RU2376309C2 (ru) | 2004-07-01 | 2009-12-20 | Асубио Фарма Ко., Лтд. | Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7 (pde 7) активность |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2681650C (en) * | 2007-03-27 | 2016-11-22 | Omeros Corporation | The use of pde7 inhibitors for the treatment of movement disorders |
US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
CN103547267A (zh) | 2010-11-08 | 2014-01-29 | 奥默罗斯公司 | 使用pde7抑制剂治疗成瘾和冲动控制障碍 |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
KR102640696B1 (ko) | 2017-07-12 | 2024-02-27 | 다트 뉴로사이언스, 엘엘씨 | Pde7 억제제로서 치환된 벤즈옥사졸 및 벤조푸란 화합물 |
WO2024038089A1 (en) | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3150486A1 (de) * | 1981-12-19 | 1983-08-25 | Merck Patent Gmbh, 6100 Darmstadt | Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung |
US5120740A (en) | 1989-11-03 | 1992-06-09 | Wisconsin Alumni Research Foundation | Prodrugs of 6-mercaptopurine and 6-thioguanine |
-
1999
- 1999-11-06 DE DE19953414A patent/DE19953414A1/de not_active Withdrawn
-
2000
- 2000-10-25 PL PL00355022A patent/PL355022A1/xx unknown
- 2000-10-25 MX MXPA02004448A patent/MXPA02004448A/es unknown
- 2000-10-25 ES ES00975916T patent/ES2192183T3/es not_active Expired - Lifetime
- 2000-10-25 JP JP2001536548A patent/JP2003513973A/ja active Pending
- 2000-10-25 US US10/129,274 patent/US6613778B1/en not_active Expired - Fee Related
- 2000-10-25 CN CN00815292A patent/CN1387530A/zh active Pending
- 2000-10-25 AU AU13872/01A patent/AU775993B2/en not_active Ceased
- 2000-10-25 CZ CZ20021416A patent/CZ20021416A3/cs unknown
- 2000-10-25 WO PCT/EP2000/010525 patent/WO2001034601A2/de active IP Right Grant
- 2000-10-25 BR BR0015324-9A patent/BR0015324A/pt not_active Application Discontinuation
- 2000-10-25 AT AT00975916T patent/ATE236157T1/de not_active IP Right Cessation
- 2000-10-25 DK DK00975916T patent/DK1226143T3/da active
- 2000-10-25 KR KR1020027005848A patent/KR20020044591A/ko not_active Application Discontinuation
- 2000-10-25 SK SK573-2002A patent/SK5732002A3/sk unknown
- 2000-10-25 PT PT00975916T patent/PT1226143E/pt unknown
- 2000-10-25 HU HU0203245A patent/HUP0203245A3/hu unknown
- 2000-10-25 CA CA002388729A patent/CA2388729A1/en not_active Abandoned
- 2000-10-25 EP EP00975916A patent/EP1226143B1/de not_active Expired - Lifetime
- 2000-10-25 DE DE50001663T patent/DE50001663D1/de not_active Expired - Lifetime
- 2000-11-03 AR ARP000105801A patent/AR026352A1/es unknown
-
2002
- 2002-05-03 NO NO20022124A patent/NO20022124D0/no not_active Application Discontinuation
- 2002-06-05 ZA ZA200204510A patent/ZA200204510B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE236157T1 (de) | 2003-04-15 |
DE19953414A1 (de) | 2001-05-10 |
DE50001663D1 (de) | 2003-05-08 |
PL355022A1 (en) | 2004-03-22 |
AU775993B2 (en) | 2004-08-19 |
US6613778B1 (en) | 2003-09-02 |
AR026352A1 (es) | 2003-02-05 |
EP1226143A2 (de) | 2002-07-31 |
WO2001034601A3 (de) | 2001-11-15 |
PT1226143E (pt) | 2003-08-29 |
CA2388729A1 (en) | 2001-05-17 |
ZA200204510B (en) | 2003-11-26 |
HUP0203245A3 (en) | 2003-12-29 |
DK1226143T3 (da) | 2003-06-30 |
AU1387201A (en) | 2001-06-06 |
EP1226143B1 (de) | 2003-04-02 |
NO20022124L (no) | 2002-05-03 |
MXPA02004448A (es) | 2004-09-10 |
CZ20021416A3 (cs) | 2002-08-14 |
CN1387530A (zh) | 2002-12-25 |
JP2003513973A (ja) | 2003-04-15 |
WO2001034601A2 (de) | 2001-05-17 |
KR20020044591A (ko) | 2002-06-15 |
NO20022124D0 (no) | 2002-05-03 |
BR0015324A (pt) | 2002-07-09 |
HUP0203245A2 (hu) | 2003-01-28 |
SK5732002A3 (en) | 2002-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2192183T3 (es) | Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii. | |
BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
AR006390A1 (es) | Derivados de lactama | |
BR0207278A (pt) | Derivados de ftalazinona-piperidina como inibidores de pde4 | |
GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
EA200500017A1 (ru) | Новые соединения | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
ES2308299T3 (es) | Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas. | |
FI971489A (fi) | Uusia bentsoksatsoleja | |
AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
ES2169573T3 (es) | Producto para el teñido oxidativo del cabello. | |
AR026351A1 (es) | Derivados de pirrol como inhibidores de la fosfodiesterasa vii | |
ES2191963T3 (es) | Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos. | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
CO5570696A2 (es) | 1-amino-alquilciclohexanos insaturados como antagonistas de los receptores nmda, 5ht3 y nicotinico neuronal | |
ES2177275T3 (es) | Derivados de oxadiazolina y su uso como insecticidas. | |
EA200100852A1 (ru) | Производные резорцина | |
EA200100517A1 (ru) | Антагонисты 5ht1 для антидепрессантной терапии | |
TW200628450A (en) | Pyridine derivatives, preparation thereof and therapeutic application thereof | |
DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
AR054414A1 (es) | Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas. | |
PA8437201A1 (es) | Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa. | |
DK415789A (da) | Tetracykliske antidepressive midler | |
CO4930268A1 (es) | BENZO[e]ISOINDOLES Y BENZO[h]ISOQUINOLINAS TRICICLICOS | |
EA200200727A1 (ru) | Новые производные индола |